Company / Total Debt
Verrica Pharmaceuticals Inc. Total Debt History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$31.0M
FY2024
5-year range
$31.0M / $42.9M
FY2023-FY2024
Trend
-27.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$31M in FY2024.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, total debt decreased 27.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $31.0M | -27.7% |
| FY2023 | $42.9M | - |
| FY2022 | - | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026